AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
Dolutegravir, Lamivudine And Tenofovir Disoproxil Fumarate in Ghana
2 products registered with FDA Ghana — 1 active, 1 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DOLUTEGRAVIR/LAMIVUDUNE/TENOFOVIR DISOPROXIL FUMARATE TABLETS (Each tablet contains Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate 50mg/300mg/300mg) | UNKNOWN-4b50a499 | — | active | 1 Sept 2026 |
| DOLUTEGRAVIR/LAMIVUDUNE/TENOFOVIR DISOPROXIL FUMARATE TABLETS (Each tablet contains Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate 50mg/300mg/300mg) | UNKNOWN-012f42f3 | — | expired | 1 Sept 2026 |
Dolutegravir, Lamivudine And Tenofovir Disoproxil Fumarate — FDA Ghana Registration Details
FDA Ghana (Ghana) has 2 registered products containing Dolutegravir, Lamivudine And Tenofovir Disoproxil Fumarate, of which 1 is currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track Dolutegravir, Lamivudine And Tenofovir Disoproxil Fumarate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.